Brazil hones reg focus of medtech competitiveness drive
This article was originally published in Clinica
Executive Summary
Brazilian regulatory agency Anvisa has launched an initiative to "promote and strengthen" domestic production and market entry of medical technology, with an emphasis on the needs of the high proportion of micro-sized and small manufacturers.